Veracyte is excited to join the American Thyroid Association (ATA) Annual Meeting. Stop by booth #301 to learn how Veracyte is using whole-transcriptome-derived analysis on every sample to provide an actionable Afirma GSC report and create the potential for novel research.

There will be 12 poster presentations, including 7 from Veracyte and 5 independent studies that utilized data from Afirma GSC and Afirma GRID (Genomic Resource for Intelligent Discovery)*, which is a research-use-only resource for analysis of molecular characteristics that may ultimately help improve the understanding of how to manage patients with thyroid nodules and thyroid cancer.

Veracyte’s Medical Director of Endocrinology, Dr. Klopper, will also provide a presentation on Friday, September 12th – more details below.

Product Theatre

FRIDAY, SEPTEMBER 12

Kierland Grand Ballroom

• 10:15 – 11:15 am

Veracyte’s Medical Director of Endocrinology Dr. Klopper will describe how Afirma’s whole-exome molecular analysis provides accurate and reproducible results to help in thyroid nodule management and represents a platform for novel research opportunities.

Data being presented during the conference:

Independent Studies

Development of a Molecular Expression Profile-based Model to Predict High-Risk Histopathologic Features of Differentiated Thyroid Cancer

Poster 237

Date: Friday, September 12th

Time: 10:15 – 11:15 am

Presented by Justin Bauzon, MD (Cleveland Clinic)

Different Features of Aggressive Cancer Behavior Exhibit Clear Variations in mRNA Expression Patterns: An Analysis of Molecular Signatures in Differentiated Thyroid Cancer

Poster 236

Date: Friday, September 12th

Time: 10:15 – 11:15 am

Presented by Justin Bauzon, MD (Cleveland Clinic)

mRNA Expression Signatures Enhance Risk Stratification in Indeterminate Thyroid Nodules

Poster 244

Date: Friday, September 12th

Time: 10:15 – 11:15 am

Presented by Lilah Morris-Wiseman, MD, FACS (John Hopkins Medicine)

The Impact of Nodule Size on Performance of Molecular Testing for Cytologically Indeterminate Thyroid Nodules

Poster 345

Date: Saturday, September 13th

Time: 10:25 – 11:25 am

Presented by Athanasios Bikas, MD, PhD (Brigham & Women’s)

Evaluating Risk of Malignancy in Thyroid Nodules Using Molecular Profiling

Late Breaking Poster 481

Date: Saturday, September 13th

Time: 10:25 – 11:25 am

Presented by Josie Yalovitser (UVM Larner College of Medicine)

Collaborative Studies

Profiling of Black and White Patients with Indeterminate Thyroid Nodules

Poster 355

Date: Saturday, September 13th

Time: 10:25 – 11:25 am

Presented by Niranjana Swaminathan, MD (The University of Alabama at Birmingham)

The Genomic Landscape of 250,000+ Thyroid Nodules Undergoing Exome-enriched RNA Sequencing

Poster 338

Date: Saturday, September 13th

Time: 10:25 – 11:25 am

Presented by Sarah Hamidi, MD (The University of Texas MD Anderson Cancer Center)

Genomic Landscape of Medullary Thyroid Carcinoma (MTC) Identified by the Afirma RNA-Sequencing Classifier: Insights from a Large Real-World Cohort

Poster 336

Date: Saturday, September 13th

Time: 10:25 – 11:25 am

Presented by Sarah Hamidi, MD (The University of Texas MD Anderson Cancer Center)

The Genomic Landscape of Thyroid Nodules in Patients > 75 Years Old

Poster 344

Date: Saturday, September 13th

Time: 10:25 – 11:25 am

Presented by Architha Kannan, MBBS (UCSF)

The Expression of Cell-Surface Targets as Potential Prognostic and Therapeutic Markers in Thyroid Tumors

Late Breaking Poster 433

Date: Thursday, September 11th

Time: 3:00 – 4:00 pm

Presented by Hannah Nieto, MBBS, PhD (University of Birmingham)

Preoperative mRNA Thyroid Nodule Expression Signatures to Predict Postoperative Thyroid Histopathology

Late Breaking Poster 442

Date: Friday, September 12th

Time: 10:15 – 11:15 am

Presented by Genevieve Spagnuolo, MD, MBS (Tufts University)

Single-Cell RNA Sequencing Analysis of Thyroid Nodule Fine Needle Biopsy Aspiration

Late Breaking Poster 470

Date: Saturday, September 13th

Time: 10:25 – 11:25 am

Presented by Caitlin Bell, MD (University of Colorado)